Injury associated with ischemia and reperfusion is a significant facto
r in a number of clinical diseases. We have completed a number of prec
linical studies investigating the blockade of leukocyte adhesion molec
ules in ischemia-reperfusion injury. In our work and in the work of ot
her investigators, monoclonal antibodies directed to CD18, P-selectin
and L-selectin were effective in reducing ischemia-reperfusion injury
to the rabbit ear and in reducing injury following hemorrhagic shock i
n both rabbits and nonhuman primates. Ischemia-reperfusion injury was
also reduced by synthetic oligosaccharide sLe(x). These studies sugges
t that adhesion blockade might be effective in the clinical setting.Bl
ood Coag Fibrinol9 (suppl 2): S17-S23 (C) 1998 Lippincott-Raven Publis
hers.